Condition: Hypertension, Pulmonary · Lung Diseases, Interstitial · Sponsor: Tectonic Operating Company, Inc.
The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertension secondary to interstitial lung disease (PH-ILD) and to assess the safety and tolerability of TX000045 in participants with PH-ILD.
This description comes directly from the study's public registry record.
Clinical Trials · +1 339 337 4053 · ClinicalTrials@tectonictx.com
Always discuss trial participation with your own doctor first.
| Phoenix | Phoenix, Arizona, United States | Recruiting |
| San Francisco | San Francisco, California, United States | Recruiting |
| Idaho | Idaho Falls, Idaho, United States | Not Yet Recruiting |
| Allen Park | Allen Park, Michigan, United States | Not Yet Recruiting |
| Krakow | Krakow, Poland | Not Yet Recruiting |
| Lublin | Lublin, Poland | Not Yet Recruiting |
| Wroclaw | Wroclaw, Poland | Not Yet Recruiting |
| Bucharest | Bucharest, Romania | Not Yet Recruiting |
| Belgrade | Belgrade, Serbia | Not Yet Recruiting |
| Sremska Kamenica | Kamenitz, Serbia | Not Yet Recruiting |
| Niš | Niš, Serbia | Not Yet Recruiting |
| Gyeonggi-Do | Gyeonggi-do, South Korea | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07473700